1 Min Read
* SteadyMed submits type A meeting request package to FDA
* SteadyMed Ltd - type A meeting is being requested in response to FDA’s August 28, refusal to file letter relating to co’s NDA for Trevyent Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.